Pharmaceuticals

Montelukast Sodium Market Growth Projection: Expected to Surpass $6.33 Billion by 2030 at 8.4% CAGR

February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the montelukast sodium market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Montelukast Sodium Market in 2030?

The montelukast sodium market size has witnessed significant expansion in recent years. It is anticipated to increase from $4.2 billion in 2025 to $4.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. This growth during the historical period can be ascribed to the long-standing clinical application of montelukast in managing asthma, a rising prevalence of allergic respiratory illnesses, its well-established safety profile for long-term treatment, widespread physician acceptance for maintenance therapy, and the availability of cost-effective generic versions.

The montelukast sodium market is anticipated to experience substantial growth over the coming years, projected to reach $6.33 billion by 2030, exhibiting a compound annual growth rate of 8.4%. This expansion during the forecast period is fueled by several factors including the increasing global prevalence of asthma and allergic rhinitis, a rise in pediatric asthma diagnoses, greater awareness of non-steroidal treatments for asthma, wider availability of respiratory medicines in developing economies, and sustained demand for oral maintenance medications. Key trends expected in this period encompass a growing uptake of leukotriene receptor antagonists in asthma treatment, an expanded application of montelukast for allergic rhinitis, the proliferation of generic montelukast sodium options, a preference for oral solid dosage forms in long-term respiratory care, and a surge in prescriptions for both pediatric and adult asthma patients.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

What Drivers Are Influencing Production Trends In The Montelukast Sodium Market?

The growing occurrence of asthma is anticipated to boost the expansion of the montelukast sodium market. Asthma, a long-term respiratory ailment, is characterized by inflammation and narrowing of the air passages, leading to recurrent episodes of wheezing, shortness of breath, chest pressure, and coughing. The rising incidence of asthma stems from various factors, including environmental contamination, exposure to allergens, genetic factors, increased urbanization, shifts in lifestyle, and respiratory infections. As a leukotriene receptor antagonist, montelukast sodium is prescribed for asthma treatment, working to prevent and control symptoms by inhibiting leukotrienes, substances that contribute to airway inflammation and constriction. For example, in October 2024, the National Asthma Council, an Australia-based non-profit body, reported that in 2023, Australia registered 474 asthma-related deaths, with 325 being females and 149 males. This number closely mirrored the 473 asthma-related fatalities documented in 2022, indicating a steady pattern in asthma mortality across both years. Consequently, the escalating prevalence of asthma is fueling the growth of the montelukast sodium market.

Which Segment Groups Are Influencing The Montelukast Sodium Market?

The montelukast sodium market covered in this report is segmented –

1) By Product: Crystal-like, Form-less Or Amorphous

2) By Dosage Form: Tablets, Oral Solutions

3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:

1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium

2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

Which Trends Are Guiding The Evolution Of The Montelukast Sodium Market?

Leading companies in the montelukast sodium market are concentrating on developing novel solutions, such as combination therapies, to offer broader relief for allergies and asthma and enhance patient adherence. Combination therapies are treatments that utilize two or more medications together in a single regimen to target multiple disease pathways for improved efficacy. For instance, in October 2025, Cadila Pharmaceuticals Ltd., an India-based pharmaceutical company, introduced Dlorfast-M tablets, a fixed-dose combination therapy containing desloratadine (5 mg) and montelukast (10 mg), for the management of allergic rhinitis and urticaria. This provides extensive symptom control by concurrently addressing both histamine and leukotriene pathways in a convenient once-daily oral dosage. The objective of this innovative formulation is to improve patient compliance and deliver long-term relief with good tolerability.

Who Are The Major Companies Operating In The Montelukast Sodium Market?

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Montelukast Sodium Market?

North America was the largest region in the montelukast sodium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Montelukast Sodium Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16123&type=smp

Browse Through More Reports Similar to the Global Montelukast Sodium Market 2026, By The Business Research Company

Montelukast Sodium Market Report 2026

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Sodium Reduction Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/sodium-reduction-ingredients-global-market-report

Sodium Benzoate Market Report 2026

https://www.thebusinessresearchcompany.com/report/sodium-benzoate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795